United Kingdom · Question · Written question
UIN 36736
NHS: Drugs
Original
Introduced
10 March 2025
Last action
17 March 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
17 March 2025
Summary
To ask the Secretary of State for Health and Social Care, what performance improvement targets he has sought from the MHRA on bringing down the licensing backlog of generic and biosimilar medicine applications.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
10 March 2025
Written question
To ask the Secretary of State for Health and Social Care, what performance improvement targets he has sought from the MHRA on bringing down the licensing backlog of generic and biosimilar medicine applications.
Source: Commons
17 March 2025
Answer
The Medicines and Healthcare products Regulatory Agency’s (MHRA) focus has been to ensure all applications received through all routes are processed on time. The MHRA has now embedded improvements in processing licencing applications into standard working...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-03-10/36736
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1782565
- uk · wq-1782565 · source updated 17 March 2025